[1] Ahuja C. S., Wilson J. R., Nori S., Kotter M. R. N., Druschel C., Curt A. & Fehlings M. G. Traumatic spinal cord injury. Nat Rev Dis Primers, 2017, 3(17018.
[2] Donovan J. & Kirshblum S. Clinical Trials in Traumatic Spinal Cord Injury. Neurotherapeutics, 2018, 15(3): 654-668.
[3] Beric A. Post-spinal cord injury pain states. Pain, 1997, 72(3): 295-298.
[4] Hou S. & Rabchevsky A. G. Autonomic consequences of spinal cord injury. Compr Physiol, 2014, 4(4): 1419-1453.
[5] Sachdeva R., Gao F., Chan C. C. H. & Krassioukov A. V. Cognitive function after spinal cord injury: A systematic review. Neurology, 2018, 91(13): 611-621.
[6] Orr M. B. & Gensel J. C. Spinal Cord Injury Scarring and Inflammation: Therapies Targeting Glial and Inflammatory Responses. Neurotherapeutics, 2018, 15(3): 541-553.
[7] Daly S., Thorpe M., Rockswold S., Hubbard M., Bergman T., Samadani U. & Rockswold G. Hyperbaric Oxygen Therapy in the Treatment of Acute Severe Traumatic Brain Injury: A Systematic Review. J Neurotrauma, 2018, 35(4): 623-629.
[8] Xing P., Ma K., Li L., Wang D., Hu G. & Long W. The protection effect and mechanism of hyperbaric oxygen therapy in rat brain with traumatic injury. Acta Cir Bras, 2018, 33(4): 341-353.
[9] Li H. Z., Chen J. F., Liu M. & Shen J. Effect of hyperbaric oxygen on the permeability of the blood-brain barrier in rats with global cerebral ischemia/reperfusion injury. Biomed Pharmacother, 2018, 108(1725-1730.
[10] Schabitz W. R., Schade H., Heiland S., Kollmar R., Bardutzky J., Henninger N., Muller H., Carl U., Toyokuni S., Sommer C. & Schwab S. Neuroprotection by hyperbaric oxygenation after experimental focal cerebral ischemia monitored by MRI. Stroke, 2004, 35(5): 1175-1179.
[11] Falavigna A., Figueiro M. P., Silva P. G. D., Conzatti L. P., Rizkalla E. B., Santos S. C. D., Quadros F. W. & Radaelli L. Hyperbaric Oxygen Therapy After Acute Thoracic Spinal Cord Injury: Improvement of Locomotor Recovery in Rats. Spine (Phila Pa 1976), 2018, 43(8): E442-e447.
[12] Wang Y., Li C., Gao C., Li Z., Yang J., Liu X. & Liang F. Effects of hyperbaric oxygen therapy on RAGE and MCP-1 expression in rats with spinal cord injury. Mol Med Rep, 2016, 14(6): 5619-5625.
[13] Yu Y., Matsuyama Y., Yanase M., Ito S., Adachi K., Satake K., Ishiguro N. & Kiuchi K. Effects of hyperbaric oxygen on GDNF expression and apoptosis in spinal cord injury. Neuroreport, 2004, 15(15): 2369-2373.
[14] Yaman O., Yaman B., Aydin F., Var A. & Temiz C. Hyperbaric oxygen treatment in the experimental spinal cord injury model. Spine J, 2014, 14(9): 2184-2194.
[15] Huang L., Mehta M. P., Nanda A. & Zhang J. H. The role of multiple hyperbaric oxygenation in expanding therapeutic windows after acute spinal cord injury in rats. J Neurosurg, 2003, 99(2 Suppl): 198-205.
[16] Yeo J. D., Stabback S. & McKenzie B. A study of the effects of hyperbaric oxygen on the experimental spinal cord injury. Med J Aust, 1977, 2(5): 145-147.
[17] Herskovits A. Z. & Guarente L. SIRT1 in neurodevelopment and brain senescence. Neuron, 2014, 81(3): 471-483.
[18] Ling H., Peng L., Wang J., Rahhal R. & Seto E. Histone Deacetylase SIRT1 Targets Plk2 to Regulate Centriole Duplication. Cell Rep, 2018, 25(10): 2851-2865.e2853.
[19] Nakamura K., Zhang M., Kageyama S., Ke B., Fujii T., Sosa R. A., Reed E. F., Datta N., Zarrinpar A., Busuttil R. W., Araujo J. A. & Kupiec-Weglinski J. W. Macrophage heme oxygenase-1-SIRT1-p53 axis regulates sterile inflammation in liver ischemia-reperfusion injury. J Hepatol, 2017, 67(6): 1232-1242.
[20] Kauppinen A., Suuronen T., Ojala J., Kaarniranta K. & Salminen A. Antagonistic crosstalk between NF-kappaB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell Signal, 2013, 25(10): 1939-1948.
[21] Sathyanarayan A., Mashek M. T. & Mashek D. G. ATGL Promotes Autophagy/Lipophagy via SIRT1 to Control Hepatic Lipid Droplet Catabolism. Cell Rep, 2017, 19(1): 1-9.
[22] Gomes B. A. Q., Silva J. P. B., Romeiro C. F. R., Dos Santos S. M., Rodrigues C. A., Goncalves P. R., Sakai J. T., Mendes P. F. S., Varela E. L. P. & Monteiro M. C. Neuroprotective Mechanisms of Resveratrol in Alzheimer's Disease: Role of SIRT1. Oxid Med Cell Longev, 2018, 2018(8152373.
[23] Zhang Q., Zhang P., Qi G. J., Zhang Z., He F., Lv Z. X., Peng X., Cai H. W., Li T. X., Wang X. M. & Tian B. Cdk5 suppression blocks SIRT1 degradation via the ubiquitin-proteasome pathway in Parkinson's disease models. Biochim Biophys Acta Gen Subj, 2018, 1862(6): 1443-1451.
[24] Han Y., Luo H., Wang H., Cai J. & Zhang Y. SIRT1 induces resistance to apoptosis in human granulosa cells by activating the ERK pathway and inhibiting NF-kappaB signaling with anti-inflammatory functions. Apoptosis, 2017, 22(10): 1260-1272.
[25] Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell, 2002, 9(3): 459-470.
[26] Sobrido-Camean D. & Barreiro-Iglesias A. Role of Caspase-8 and Fas in Cell Death After Spinal Cord Injury. Front Mol Neurosci, 2018, 11(101.
[27] Lee I. H., Cao L., Mostoslavsky R., Lombard D. B., Liu J., Bruns N. E., Tsokos M., Alt F. W. & Finkel T. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proceedings of the National Academy of Sciences of the United States of America, 2008, 105(9): 3374-3379.
[28] Romeo-Guitart D., Leiva-Rodriguez T., Fores J. & Casas C. Improved Motor Nerve Regeneration by SIRT1/Hif1a-Mediated Autophagy. Cells, 2019, 8(11):
[29] Okada S., Hara M., Kobayakawa K., Matsumoto Y. & Nakashima Y. Astrocyte reactivity and astrogliosis after spinal cord injury. Neurosci Res, 2018, 126(39-43.
[30] Bracken M. B., Shepard M. J., Collins W. F., Holford T. R., Young W., Baskin D. S., Eisenberg H. M., Flamm E., Leo-Summers L., Maroon J. & et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med, 1990, 322(20): 1405-1411.
[31] Patel N. P. & Huang J. H. Hyperbaric oxygen therapy of spinal cord injury. Med Gas Res, 2017, 7(2): 133-143.
[32] Tran A. P., Warren P. M. & Silver J. The Biology of Regeneration Failure and Success After Spinal Cord Injury. Physiol Rev, 2018, 98(2): 881-917.
[33] Qiu G., Li X., Che X., Wei C., He S., Lu J., Jia Z., Pang K. & Fan L. SIRT1 is a regulator of autophagy: Implications in gastric cancer progression and treatment. FEBS Lett, 2015, 589(16): 2034-2042.
[34] Ng F. & Tang B. L. Sirtuins' modulation of autophagy. J Cell Physiol, 2013, 228(12): 2262-2270.